A Study of CDP870 as Add-on Meditation to Methotrexate (MTX) in Patients With Rheumatoid Arthritis
Clinical trial NCT00993317 · COMPLETED
Trial details
- NCT number
- NCT00993317
- Sponsor
- Korea Otsuka Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2011-08-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.